Walmart rolls out first private-brand
analog insulin for diabetes
The company says the new insulin will be available at Walmart pharmacies this week and at Sam's Club next month. File Photo by Brian Kersey/UPI | License Photo
June 29 (UPI) -- Walmart announced Tuesday that it is launching its first-ever private-brand insulin that it says will save customers on the diabetes treatment.
The company said the ReliOn NovoLog Insulin will be available at Walmart locations this week and Sam's Club in mid-July.
The insulin is manufactured by Denmark-based Novo Nordisk.
Customers will need a prescription for the rapid-acting insulin analog, which is used to control blood sugar in adults and children.
The brand will offer insulin vials for about $73 and a FlexPan for $86, Walmart said. The retailer said the brand will save shoppers 50% to 75%.
"We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions," Walmart Health and Wellness Executive Vice President Dr. Cheryl Pegus said in a statement.
"We also know this is a condition that disproportionately impacts underserved populations."
Walmart already sells a lower-price insulin, but it's an older formulation that is typically not as effective as newer, analog versions.
The company says the new insulin will be available at Walmart pharmacies this week and at Sam's Club next month. File Photo by Brian Kersey/UPI | License Photo
June 29 (UPI) -- Walmart announced Tuesday that it is launching its first-ever private-brand insulin that it says will save customers on the diabetes treatment.
The company said the ReliOn NovoLog Insulin will be available at Walmart locations this week and Sam's Club in mid-July.
The insulin is manufactured by Denmark-based Novo Nordisk.
Customers will need a prescription for the rapid-acting insulin analog, which is used to control blood sugar in adults and children.
The brand will offer insulin vials for about $73 and a FlexPan for $86, Walmart said. The retailer said the brand will save shoppers 50% to 75%.
"We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions," Walmart Health and Wellness Executive Vice President Dr. Cheryl Pegus said in a statement.
"We also know this is a condition that disproportionately impacts underserved populations."
Walmart already sells a lower-price insulin, but it's an older formulation that is typically not as effective as newer, analog versions.
No comments:
Post a Comment